Increased interleukin-32, interleukin-1, and interferon-γ levels in serum from hepatitis B patients and in HBV-stimulated peripheral blood mononuclear cells from healthy volunteers
Authors:
Open Access
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 12 (1) , 7-12
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Shandong Province
This publication has 14 references indexed in Scilit:
- Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-κBMolecular Immunology, 2011
- Interleukin-32: A new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosisHepatology, 2011
- Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expressionof interleukin-32 controls the expression of the humanpapillomavirus oncogeneImmunology, 2011
- HBV Life Cycle: Entry and MorphogenesisViruses, 2009
- A sensitive direct sequencing assay based on nested PCR for the detection of HBV polymerase and surface glycoprotein mutationsJournal of Virological Methods, 2009
- Fas / FasL system, IL‐1β expression and apoptosis in chronic HBV and HCV liver diseaseJournal of Viral Hepatitis, 2008
- Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replicationImmunology Letters, 2008
- IL-32, a proinflammatory cytokine in rheumatoid arthritisProceedings of the National Academy of Sciences, 2006
- IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1β and IL-6 production through a caspase 1-dependent mechanismProceedings of the National Academy of Sciences, 2005
- IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complexNature Immunology, 2002